The home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea ...

Early CPAP treatment for individuals with OSA may help reduce the onset of Parkinson disease and other neurodegenerative diseases.

NightOwl, an FDA-cleared home sleep apnea test (HSAT) offers a simplified, accurate, efficient way to diagnose obstructive sleep apnea (OSA). It adds another offering to Resmed’s portfolio, which is ...

Which is the better option for ASX investors, Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) or ResMed Inc. (ASX: RMD) ...

NightOwl is now widely available across the United States. Individuals interested in NightOwl should speak with their healthcare provider for more information. To learn more, visit: https://www.resmed ...

We recently published a list of Jim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings Season. In this article, we are ...

A big reason for Resmed’s recently announced rebrand is to reflect its increased direct-to-consumer engagement on obstructive ...

SAN DIEGO (Ivanhoe Newswire) — Obstructive sleep apnea or OSA affects nearly 1 billion ... But still, wearing the noisy mask hooked up to a bulky hose is better than no sleep at all.

(RTTNews) - Resmed Inc (RMD) Wednesday said it has published a meta analysis in The Lancet Respiratory Medicine showing that CPAP therapy significantly reduces the risk of death for people with ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. Many investors also have a go-to methodology that helps guide their buy ...